Table 3.
Teicoplanin type glycopeptides and their derivatives 
| LCTA | Code no. | X | Y | Z | HIV-1 (CEM) |
FIPV (CRFK) |
SARS-CoV (Vero) |
|||
|---|---|---|---|---|---|---|---|---|---|---|
| EC50 (μM) | IC50 (μM) | EC50 (μM) | CC50 (μM) | EC50 (μM) | CC50 (μM) | |||||
| Ristomycin (Risto) W1 = W2 = W3 = H, W4 = Me, S1 = tetrasaccharide, S2 = ristosamine, S3 = Man, S4 = OH | ||||||||||
| 903 | 50 | H | OMe | H | >250 | >500 | >80 | >80 | >80 | >80 |
| Ristosaminylaglycon of ristomycin W1 = W2 = W3 = S1 = S3 = H, W4 = Me, S2 = ristosamine, S4 = OH | ||||||||||
| 929 | 51 | H | OMe | H | >50 | >100 | >80 | >80 | >80 | >80 |
| Teicoplanin (Teico) and its derivatives W1 = W2 = Cl, W3 = W4 = H, S1 = GlcNAcyl, S2 = GlcNAc, S3 = Man, S4 = H | ||||||||||
| 879 | 52 | H | OH | H | 18 | >500 | >80 | >80 | >100 | >100 |
| 894 | 53 | H | NH(CH2)3N+Me2C10H21 | H | >10 | 54 ± 9 | >80 | >80 | >80 | >80 |
| 895 | 54 | H | NHMe | H | 80 ± 28 | >500 | >80 | >80 | >80 | >80 |